Fortitude Family Office »

Oric Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.9k 574 13.75
2023-12-31 $5.3k 574 9.20

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Vanguard Mid-cap Etf Etf (VO)
Ishares Tips Bond Etf Etf (TIP)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Jpmorgan Ultra-short Income Etf Ultra Short Income Fund Etf (JPST)
Kkr & Co Stock (KKR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Vanguard Ftse Emerging Markets Etf Etf (VWO)

View all positions for Fortitude Family Office

Top funds holding Oric Pharmaceuticals

Nextech Invest
Column Group
EcoR1 Capital
VR Adviser
Vanguard Group
Frazier Life Sciences Management
Arrowpoint Asset Management
Boxer Capital
Invus Financial Advisors
Euclidean Capital
Vivo Capital
Franklin Resources
Henderson Group
T. Rowe Price Associates
OrbiMed Advisors

View all funds holding Oric Pharmaceuticals